Ghana—One Year Later

Earlier this year at the 2nd Global Cervical Cancer Elimination Forum in Bali, world leaders and the World Health Organization (WHO) reaffirmed a bold mission: Eliminate cervical cancer through HPV vaccination, expanded screening, and access to treatment.

For us, this mission resonates deeply. Cervical cancer is preventable, yet it remains one of the leading causes of cancer-related death for women. The solution lies in access, training, and technology—and Ghana has shown the world how powerful this combination can be.

One year ago, our team at Lutech joined forces with AGES Ghana (led by Dr. Barbara Entsuah & Jojo Entsuah), in collaboration with Her Health EQ and CEO Marissa Fayer, to launch a groundbreaking initiative. Together with the Cervical Cancer Prevention and Training Center (CCPTC) and Dr. Kofi Effah, they installed ten Lutech Digital Colposcopes, trained providers, and launched mobile outreach across hospital systems in Ghana.

A recent publication in The Journal of Lower Genital Tract Disease by Iffat Elbarazi, DrPH, and Luai A. Ahmed, PhD explains the importance of these efforts, showing that sustainable, community-based programs—supported by mobile colposcopy—can expand access to life-saving screening and early detection.

In one year 16,000 women were screened as part of our initiative. The program demonstrates a replicable framework for countries working toward the WHO’s goal of eliminating cervical cancer:

• Partnerships that cross boundaries
  Collaboration between local leaders (AGES Ghana), global health NGOs (Her Health EQ), and training institutions (CCPTC) created alignment, resources, and shared accountability.
• Training for sustainability
  Midwives gained hands-on colposcopy experience under Dr. Effah’s guidance, ensuring skills stay within the community and continue to expand.
• Technology built for accessibility
  The Lutech Mobile Colposcope delivers the same imaging quality as larger, stationary, in-office devices. The light-weight, LT-300HD is portable and adaptable, bringing screenings to women where they live, not just where hospitals are located.

 

Why Colposcopy Matters 

Alleviating the Global Burden of Cancer Through Prevention and Early Detection calls for an integrated approach to screenings and prevention, health education, policy reform, and technological advancements to reduce the global burden of cancer. While HPV vaccination and primary screening are critical steps, colposcopy exams ensure women receive accurate diagnosis and timely treatment. Without access to colposcopy in remote areas, the elimination effort cannot succeed.

In Ghana, we saw this firsthand. Women in rural areas had to travel long distances for screenings, follow-up care and often did not return for treatment. By introducing the Lutech Mobile Colposcope, we created new opportunities for providers to bring high-quality screening and treatment directly to the community.

 

The Lutech Mobile Colposcope in Action

In the year since our Ghana project began, Lutech colposcopes have continued to support providers and expand access to screening 16,000 women. Seeing that local impact makes the global commitments announced in Bali even more powerful. Our mobile colposcope is designed for the very settings highlighted at the Bali forum. It provides:

• Light-Weight Portability: Easily transported to rural hospitals, community health centers, and mobile clinics.
• High-Definition Imaging: Accurate visualization that meets the same standard as in-office exams.
• Laptop and Smartphone Compatibility: Flexibility to fit existing resources and workflows.
• Trauma-Informed Design: A more comfortable, respectful exam experience that encourages participation.
• Educational Engagement: On-screen viewing allows women to be part of their own care.

 

Global Initiatives for Cervical Cancer Elimination

The global goal of cervical cancer elimination is only achievable if innovation reaches underserved communities. Our partnership with Her Health EQ in Ghana is living proof that mobile colposcopy can close the gap.

The WHO’s message from Bali is clear: Cervical cancer can be eliminated within our lifetime. But it will take more than vaccines and screening tests, it requires the tools that make follow-up diagnosis and treatment possible everywhere one might live.

For Nations committed to reducing the burden of cervical cancer, the Ghana experience offers a clear roadmap:

1. Identify strong partners – healthcare leaders, NGOs, training centers, and technology providers.
2. Invest in training – empower midwives, nurses, and frontline workers to scale screening efforts.
3. Choose the right tools – mobile colposcopes ensure access in both urban and rural communities.
4. Build sustainability – track data, monitor outcomes, and ensure local ownership of the program.

The success in Ghana proves that cervical cancer elimination is not only possible, it is within reach. By replicating this model of partnership, training, and mobile technology, other countries can create their own success stories and accelerate progress toward a world where no woman dies from a preventable disease. We are proud to say that Lutech’s mobile colposcope is not just a device. It is part of a movement. From Ghana to Bali and beyond, this anniversary is more than a milestone. It is a reminder that with the right partnerships, technology, and vision, we can make cancer elimination not just a goal but a reality.

 

Ready to learn more?

See how the LT-300HD can enhance cervical cancer screenings at your practice. Contact us today for a demo or call to speak with a member of our team.